Novel Transgenic Rice-Based Vaccines

Tatsuhiko Azegami, Hiroshi Itoh, Hiroshi Kiyono, Yoshikazu Yuki

研究成果: Review article査読

17 被引用数 (Scopus)

抄録

Oral vaccination can induce both systemic and mucosal antigen-specific immune responses. To control rampant mucosal infectious diseases, the development of new effective oral vaccines is needed. Plant-based vaccines are new candidates for oral vaccines, and have some advantages over the traditional vaccines in cost, safety, and scalability. Rice seeds are attractive for vaccine production because of their stability and resistance to digestion in the stomach. The efficacy of some rice-based vaccines for infectious, autoimmune, and other diseases has been already demonstrated in animal models. We reported the efficacy in mice, safety, and stability of a rice-based cholera toxin B subunit vaccine called MucoRice-CTB. To advance MucoRice-CTB for use in humans, we also examined its efficacy and safety in primates. The potential of transgenic rice production as a new mucosal vaccine delivery system is reviewed from the perspective of future development of effective oral vaccines.

本文言語English
ページ(範囲)87-99
ページ数13
ジャーナルArchivum Immunologiae et Therapiae Experimentalis
63
2
DOI
出版ステータスPublished - 2015 4

ASJC Scopus subject areas

  • 免疫アレルギー学
  • 免疫学

フィンガープリント

「Novel Transgenic Rice-Based Vaccines」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル